calcium acetatemagnesium carbonate fixeddose combination drug contains mg calcium mg magnesium ions indicated phosphate binder dialysis patients hyperphosphataemia abnormal high serum phosphorus registered fresenius medical care trade names renepho belgium osvaren number european countries phosphorus contained food high protein content well processed food absorbed small healthy kidneys remove excess phosphorus body one consequences renal failure inadequate removal phosphorus resulting increased serum phosphorus levels may worsen overproduction parathyroid hormone hyperparathyroidism may lead renal osteodystrophy calcification blood vessels associated cardiovascular mortality socalled chronic kidney diseasemineral bone disorder addition dialysis therapy dietary restrictions pharmaceutical therapy lower serum phosphorus levels calcium acetatemagnesium carbonate taken orally together calcium acetate magnesium carbonate compounds bind phosphorus derived food thereby forming indigestible phosphate salts intestine subsequently excreted faeces aim therapy reach normal serum phosphorus level ie mmoll side effects pharmaceutical therapy gastrointestinal disorders eg nausea constipation diarrhoea may occur well metabolism nutritional disorders eg hypercalcaemia httpsenwikipediaorgwikicalciumacetatemagnesiumcarbonate